当前位置: X-MOL 学术J. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Blood mitochondrial DNA levels remain elevated from birth to early life in children HIV-exposed uninfected exposed to combination antiretroviral therapy in utero.
The Journal of Infectious Diseases ( IF 6.4 ) Pub Date : 2020-07-08 , DOI: 10.1093/infdis/jiaa410
Abhinav Ajaykumar 1, 2 , Mayanne Zhu 1 , Fatima Kakkar 3 , Jason Brophy 4 , Ari Bitnun 5 , Ariane Alimenti 6, 7 , Hugo Soudeyns 8, 9 , Sara Saberi 1, 2 , Arianne Y K Albert 10 , Deborah M Money 7, 10, 11 , Hélène C F Côté 1, 2, 10 ,
Affiliation  

Combination antiretroviral therapy (cART) during pregnancy prevents vertical transmission, but many antiretrovirals cross the placenta and several can affect mitochondria. Exposure to maternal HIV and/or cART could have long-term effects on children HIV-exposed uninfected (CHEU). Our objective was to compare blood mitochondrial DNA (mtDNA) content in CHEU and children HIV-unexposed uninfected (CHUU), at birth and in early life.

中文翻译:

在未感染 HIV 的儿童中,在子宫内接受联合抗逆转录病毒治疗的儿童从出生到生命早期,血液中的线粒体 DNA 水平一直处于升高状态。

怀孕期间的联合抗逆转录病毒疗法 (cART) 可防止垂直传播,但许多抗逆转录病毒药物会穿过胎盘,其中一些会影响线粒体。暴露于母亲 HIV 和/或 cART 可能对未感染 HIV 的儿童 (CHEU) 产生长期影响。我们的目标是比较 CHEU 和未暴露于 HIV 的儿童 (CHUU) 在出生时和生命早期的血液线粒体 DNA (mtDNA) 含量。
更新日期:2020-07-08
down
wechat
bug